The Clinical Trials Support Office in the Medical School Office of Research has been actively working to create the infrastructure to better support our clinical trial activity.
Moving forward with new processes for managing clinical trials here at the university, a key item on the Clinical Trials Support Office’s “to do” list is transitioning currently active trials under the umbrella of their appropriate Clinical Trials Support Unit into OnCore, the new Clinical Trials Management System. The Clinical Trials Support Office will be partnering with investigators and their teams between October 2017 and July 2018 to migrate non-oncology clinical trials, and oncology trials will begin migrating later in 2018.
If you are a Medical School investigator or study team member with an existing IRB-approved trial, check out the preliminary timeline (Level 1 password sign in) for when your trial is tentatively scheduled to make the transition. This timeline is preliminary, and the Clinical Trials Support Office will be systematically reaching out to schedule an in-person meeting at least two months in advance with each study team to verify that studies on the list meet the U-M/NIH definition of a clinical trial and are still active (i.e. study visits still occurring), discuss the process, and confirm a final migration date. Look for an email from Teri Grieb, Senior Director for Research, to schedule the meeting.
“In a day-to-day, practical sense, migrating our existing trials to OnCore and the appropriate Clinical Trials Support Unit will help prevent teams from having to juggle multiple systems,” notes Anna Lok, MD and Assistant Dean for Clinical Research. “And in the long run, we’ll have a much deeper understanding of our entire clinical trial portfolio, which will help make us better partners for potential sponsoring organizations and ultimately move new therapeutics and technologies into the clinic faster.”
Learn more about the latest activities of the Clinical Trials Support Office at their website.